Background Fatigue is an important aspect of disease both in rheumatoid arthritis (RA) and
in psoriatic arthritis (PsA) and is of high priority for patients. In RA, a recent Cochrane meta …

Objectives Fatigue is a significant issue in psoriatic arthritis. The objective was to assess the
effect of biological disease modifying antirheumatic drugs and apremilast on fatigue in …

Background Psoriatic arthritis (PsA) is a chronic inflammatory disorder associated with
fatigue, pain and impaired function. Tumour necrosis factor inhibitor (TNFi) therapy fails …

Background Fatigue is an important symptom associated with active psoriatic arthritis (PsA)
and can impact on health-related quality of life (HRQoL) and social functioning …

Objective The objective of this population-based cohort study was to investigate the
association between fatigue with disease activity and drug survival in patients with psoriatic …

Background: In patients (pts) with psoriatic arthritis (PsA), fatigue is a major driver of
perceived impact of disease and has been identified as an important domain to be assessed …

Background Fatigue is a common constitutional feature and has a significant impact on
quality of life in patients with chronic inflammatory rheumatic diseases, such as psoriatic …

Objectives: Fatigue is a prominent symptom in patients with psoriatic arthritis (PsA). There
was a wide variety of statistics previously reported on fatigue prevalence in patients. This …

Background Fatigue has been identified as one of the most significant symptoms and an
outcome of great importance to patients with psoriatic arthritis (PsA), but the association …

Abstract Background/Aims Fatigue is a prominent and debilitating symptom. Many clinicians
indicate that they may not assess fatigue frequently because there are no guidelines for …